Market Dynamics
South Africa’s AdBlue oil market was valued at USD 194.6 million in 2020 and is expected to register a CAGR of 4.91% to reach USD 281.3 million by the end of 2028. In terms of volume, the market accounted for 356.1 kilotons in 2020 and the demand is projected to reach 483.5 kilotons by the end of 2028. AdBlue, also known as Diesel Exhaust Fluid (DEF), is a blend or an aqueous solution of 32.5% urea and 67.5% of deionized water.

It primarily uses a consumable fluid in diesel and gasoline fuel-based vehicles through selective catalytic reduction (SCR) technology. The product effectively reduces the emission of oxides of nitrogen by chemically reacting with the exhaust gases.

The prominent factor driving the South Africa demand for AdBlue oil is the increasing penetration of passenger cars and commercial vehicles in the African market, wherein South Africa is a lucrative region. In addition to this, the gradual adoption of the global emission norms is likely to boost the consumption of AdBlue oil in the country.

Moreover, changing lifestyle and gradually increasing disposable income of the people in this country are favoring the market growth. However, sluggish economic growth of South Africa on the backdrop of the looming macroeconomic factors is expected to hamper the market growth. Furthermore, fluctuating prices of urea, one of the major raw materials of AdBlue affects the market growth.

Nevertheless, the growing use of emission reduction product in agricultural machinery and construction equipment is expected to mitigate the market restraints in the coming years.

Market Segmentation
South Africa AdBlue oil market has been segmented by application. Based on the application, the market has been segmented into automotive, construction machinery, farm machinery, electronic generators, railway engines, and others.

Automotive is the largest consumer of AdBlue, which accounted for 62.27% share of the market in 2020. This segment is estimated to register the highest CAGR of 5.24% to reach USD 179.7 million by the end of 2028. This growth is mainly attributed to the increasing demand for passenger and commercial vehicles, along with stringent emission norms.

Key end consumers of AdBlue oil include the automotive, construction, and agriculture industries. These industries account for around 80% of the South Africa AdBlue oil market. The demand from the automotive and construction industry has experienced a significant decline primarily due to the shutting down of factories and businesses worldwide, resulting in insufficient availability of raw materials, thereby affecting production on a global scale.

Major Players
The key competitors operating in the global South Africa AdBlue Oil Market are Yara, BASF SE, Engen Petroleum Ltd., and Viscol. Co.Za.

The post South Africa AdBlue Oil Market Research Report forecast 2027 first appeared on CRI Report.

In India, there are approximately 562 medical colleges under the National Medical Commission (NMC). Admission to medical institutions is based on the National Eligibility Entrance Test (NEET) ranks. There are ~50.89% government medical colleges and ~49.11% private medical colleges in the country. The private medical colleges are equipped with advanced laboratories, along with highly-educated teaching faculty.

Market insights:
Private medical institutions have more number of seats than government medical colleges but admission charges and cost of the course are significantly high. At present there are 276 private medical colleges in India.

According to an NMC data, around 37 applications were received to establish private medical colleges for the academic year 2021 – 2022. Around 15 private medical colleges were set up between 2020 and 2021.

Increase in the number of seats in private medical colleges and growing investment opportunities for the same are some of the important factors driving the growth of the market. However, inadequate healthcare infrastructure, inappropriate doctor to patient ratio and high admission and course fees are the key challenges to the growth of the market.

Moreover, Medical facilities are not equitably distributed throughout the country. Patients are sometimes required to go abroad for treatment purposes as they are unsure about the success rate of the therapy in India. Several seats in private colleges are reserved for management quota, thus, blocking the seats of some deserving candidates.

Although the number of medical seats has increased, it is still not sufficient because of the vast population of the country.

Impact of COVID-19:
Several private medical colleges were converted into COVID-19 hospitals in 2020. Most of them were used as quarantine centers for infected patients to remain isolated. The All India Council for Technical Education (AICTE) issued a circular instructing the listed institutes and colleges not to insist on payment of fees, including admission charges.

However, in private colleges and deemed universities, medical students, many of whom are at the forefront of India’s medical response to the COVID-19 pandemic, have received no such protection.

Government initiatives:
The Ministry of Health and Family Welfare (MOHFW) announced a centrally-sponsored scheme in 2021 to upgrade existing state/central government medical colleges to raise the number of MBBS seats. 90% of the investment is made by central government and the rest is borne by the states.

Under public-private partnerships, the central government will fund the viability gap to the tune of 60% -80% of the cost of establishing medical colleges in existing district hospitals.

Related:Healthcare Education Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

The post Private Medical Colleges Market in India 2021 first appeared on CRI Report.

The consumer landscape in the healthcare industry in India is expected to evolve during the 2019-2024 period. A paradigm shift is anticipated from volume-based care (fee-for-service healthcare, being independent of the service quality) to value-based care (healthcare providers are charged based on patients’ health outcomes).

Stakeholders in the Indian healthcare ecosystem are focusing on leveraging healthcare apps to make up for the inadequacies in healthcare infrastructure.

Increasing focus on patient-centric care, the emergence of advanced technologies, and changing business models have played a crucial role in driving the healthcare apps market in India. In terms of revenue, the healthcare apps market in India was valued at INR 27.01 Bn in 2018 and is estimated to reach INR 138.00 Bn by 2024, expanding at a CAGR of ~31.61% during the 2019-2024 period.

The demand for healthcare apps with differentiated services is projected to increase because it meets the varying expectations of consumers. Wellness management and appointment scheduling apps have witnessed wide popularity among consumers. The demand for chronic disease management apps is expected to witness rapid growth over the next few years.

Market Influencers

Digital transformation in the country, coupled with substantial support from the government, has fueled the growth of the healthcare apps market in India. The increase in digital reach in the country has been replicated by a swift growth in the number of mobile subscribers and Internet users in the country. The number of mobile application downloads has increased at an exponential rate from 6.5 Bn in 2016 to 12.1 Bn in 2017.

Internet service providers are offering mobile data at a low price to sustain in the competitive market, resulting in a monthly data consumption per unique connection, from 86 MB in 2014 to 8,320 MB in 2018. Thus, the increase in Internet density and the rise in the number of Internet users are driving the healthcare apps market in India.

The Indian government played a key role in the growth of healthcare apps market. The introduction of the National Health Policy in 2017 stimulated the adoption of various digital tools, including healthcare apps. Some of the major healthcare apps launched by the government include E-RaktKosh, Mera Aspataal/My Hospital, No More Tension, and Swasth Bharat.

The market has been experiencing significant challenges due to the lack of awareness, security issues, and uncertain app performance. Moreover, most consumers’ interest is limited to fitness and wellness management with a lack of knowledge regarding the diverse types of healthcare apps (disease-specific apps, medication reminder apps) available.

Furthermore, stakeholders are uncertain about the performance and efficiency of apps, owing to the unavailability of clinical performance data. The limited availability of app content in Indian languages also acts as an adoption barrier for healthcare apps.

Technology insights

Healthcare apps available in India mostly run on Android, iOS, and Windows platforms, which can be downloaded from the Google Play Store, Apple App Store, and Microsoft Store (for Windows phone). The introduction of advanced technologies like the Internet of Things (IoT), artificial intelligence (AI), Blockchain, and virtual reality are expected to disrupt the healthcare apps market.

The health data generated from healthcare apps can be leveraged by AI and machine learning algorithms and used to identify people with potential health risks. Further, an AI-based app can detect patients’ faces through a visual recognition system and assist in disease management. Internet of Medical Things (IoMT) has the potential to develop innovative apps, which connect to beacons placed across hospitals and aid indoor navigation within hospitals.

Competitive insights

The highly competitive healthcare apps market in India is fragmented with the presence of various small and medium-sized players. The prospective market has motivated several non-healthcare companies, including IT and software development companies, technology companies, and app development agencies to begin their operations in the country.

However, the market is yet in a nascent stage, and thus, players are experimenting with different business models to accomplish monetization. Among various models, licensing, third-party app development, in-app advertising, and pay-per-download have achieved significant success.

Companies covered

• Abbott India Ltd.
• HealthifyMe Wellness Pvt. Ltd.
• Infomoko Technology Pvt. Ltd.
• Kare4u Healthcare Solutions Pvt. Ltd.
• Lybrate India Pvt. Ltd.
• MediIT Health Solutions India Pvt. Ltd
• One Eighty Aamoksh Technologies Pvt Ltd.
• Portea Medical
• Practo Technologies Pvt. Ltd.
• Zoctr Health Pvt. Ltd.

Global Digital Health Market: Market Segments: By Technology (Mobile Health, Electronic Health Record, Telemedicine & Healthcare Analytics); By Component (Software, Hardware and Services); By End User (B2B & B2C); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030

The post Healthcare Apps Market in India 2019 first appeared on CRI Report.

Market Segment Analysis:
Based on product type, in 2019, the wristband segment would occupy the highest market share (~47.90%), followed by the newly emerging segment of ear-worn devices, with a market share of ~44.40%. Earlier, earwear devices were less popular. However, with the transition from wired earphones to wireless technology, Bluetooth-enabled earphones became prevalent, and the earwear segment became a significant contributor to the wearable devices market. Also, major smartphone companies discontinued providing earphones with phones as an accessory, which accelerated the growth of earwear devices further. However, the wristband segment, which still occupies a considerable market share, is witnessing saturation levels in its growth trajectory and significant decline in its demand with the growing popularity of applications that run on Android and iOS, like HealthifyMe and MyFitnessPal. These low-cost counterparts are perfect substitutes for expensive wearables, as they are programmed to perform similar kind of functions as wristbands. On the other hand, the smartwatch segment has lost its market by ~5.60% over the last three years due to the high price range of smartphones and considerably lower value proposition. Overall, the shipment volume of wearable devices has experienced a growth of around 25.53% from 2018 to 2019.

Competition Analysis:
By the end of 2018, the Chinese multinational company, Xiaomi Technology India Private Limited managed to be the leading player in the wearable devices market in India, followed by GOQii Technologies Private Limited, and Titan Company Limited. Other major players in the market are Fitbit India Private Limited, Fossil India Private Limited, and Samsung India Electronics Private Limited. Xiaomi Mi Band 3 (a fitness band launched by Xiaomi in September, 2018) was the highest-selling wearable device in India till March 2019. The upgraded version of the same fitness band, Xiaomi Mi Band 4, launched in September 2019, has already gained a considerable momentum so far.

Companies Covered
• Titan Company Limited
• Apple India Private Limited
• Fitbit India Private Limited
• Fossil India Private Limited
• Garmin India Private Limited
• Google India Private Limited
• GOQii Technologies Private Limited
• Huawei India Private Limited
• Samsung India Electronics Private Limited
• Xiaomi Technology India Private Limited

Customizations available:
With the given market data, Netscribes offers customizations according to specific needs. Write to us at info@netscribes.com

The post Wearable Devices Market in India 2019 first appeared on CRI Report.

Key Players
Some of the key players in this market are: AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others.
Study Objectives:
Ø To provide insights about factors, influencing and affecting the market growth.
Ø To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
Ø To provide historical and forecast revenue of the market segments based on types, diagnosis, and treatment.
Ø To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.

Target Audience
• Uterine Fibroid Devices and Drug Manufacturers
• Uterine Fibroid Devices and Drug Suppliers
• Private Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Medical Research Laboratories

Key Finding
• The U.S. Uterine Fibroid market and is expected to reach USD 39,993.2 million by 2022.
• By Type, Intramural Fibroids holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 14,972.5 million by 2022.
• By Treatment, hysterectomy holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 8,042.3 million by 2022.

The reports also cover country level analysis:
America
• North America
Europe
Western Europe
• Germany
• France
• Italy
• Spain
• UK
• Rest of Western Europe
• Eastern Europe
Asia
• China
• India
• Japan
• South Korea
• Rest of Asia
Middle East & Africa

1 Introduction
1.1.1 Prevalence of the Uterine Fibroids in U.S.
2 Scope of Study
2.1 Research Objective
2.2 Assumptions & Limitations
2.2.1 Assumptions
2.2.2 Limitations
2.3 Market Structure
3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
4 U.S. Uterine Fibroid Market
4.1 Introduction
4.2 U.S. Uterine Fibroid Market, By Type
4.3 U.S. Uterine Fibroid Market, By Diagnosis
4.4 U.S. Uterine Fibroid Market, By Treatment
5 Company Profile
5.1 AstraZeneca
5.1.1 Company Overview
5.1.2 Product overview
5.1.3 Financial Overview
5.1.4 Key Development
5.1.5 SWOT Analysis
5.2 Cook Medical Inc.
5.2.1 Overview
5.2.2 Product Overview
5.2.3 Financials
5.2.4 Key Developments
5.2.5 SWOT Analysis
5.3 Boston Scientific Corporation
5.3.1 Company Overview
5.3.2 Product/Business Segment Overview
5.3.3 Financial Overview
5.3.4 Key Development
5.3.1 SWOT Analysis
5.4 GE Healthcare
5.4.1 Company Overview
5.4.2 Product/Business Segment Overview
5.4.3 Financial Overview
5.4.4 Key Development
5.4.5 SWOT Analysis
5.5 AbbVie Inc.
5.5.1 Company Overview
5.5.2 Product/Business Segment Overview
5.5.3 Financial Overview
5.5.4 Key Development
5.5.5 SWOT Analysis
5.6 Hologic, Inc.
5.6.1 Company Overview
5.6.2 Product/Business Segment Overview
5.6.3 Financial Overview
5.6.4 Key Development
5.6.5 SWOT Analysis

The post U.S. Uterine Fibroid Market Research Report – Forecast to 2022 first appeared on CRI Report.